Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Down-regulation of CYP27B1 gene expression in Iranian patients with relapsing-remitting multiple sclerosis

Down-regulation of CYP27B1 gene expression in Iranian patients with relapsing-remitting multiple... BACKGROUND: Multiple sclerosis (MS) as a complex neurologicaldisease can be due to vitamin D deficiency. CYP27B1 is referred to as avitamin D metabolizing enzyme. MATERIALS AND METHODS: This studycompared the expression level of CYP27B1 in Relapsing-Remitting MS (RRMS)patients with normal individuals in Iran. The RNA was extracted from 50 RRMSpatients and 50 normal controls. Quantitative RT-PCR was adopted to measurethe expression level of CYP27B1 gene. RESULTS: The expression levelof CYP27B1gene was significantly lower in the RRMS patients than theirnormal counterparts (P value = 0.04). Also, the RRMS females participating hada significant reduction in CYP27B1 gene expression compared to normalfemales (P-Value = 0.01). In addition, the correlation between CYP27B1expression level, and the risk of Expanded Disability Status Scaleof Kurtzke (EDSS) was not linear. Additionally, there was no significantcorrelation between expression status of CYP27B1gene and duration of thedisease. CONCLUSION: A significant decrease in the expression levelof CYP27A1 in female patients could indicate their greater vulnerability toMS than the male patients. http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Human Antibodies IOS Press

Down-regulation of CYP27B1 gene expression in Iranian patients with relapsing-remitting multiple sclerosis

Loading next page...
 
/lp/ios-press/down-regulation-of-cyp27b1-gene-expression-in-iranian-patients-with-m0B0qVJSYI

References (26)

Publisher
IOS Press
Copyright
Copyright © 2016 IOS Press and the authors. All rights reserved
ISSN
1093-2607
eISSN
1875-869X
DOI
10.3233/HAB-160297
pmid
27792005
Publisher site
See Article on Publisher Site

Abstract

BACKGROUND: Multiple sclerosis (MS) as a complex neurologicaldisease can be due to vitamin D deficiency. CYP27B1 is referred to as avitamin D metabolizing enzyme. MATERIALS AND METHODS: This studycompared the expression level of CYP27B1 in Relapsing-Remitting MS (RRMS)patients with normal individuals in Iran. The RNA was extracted from 50 RRMSpatients and 50 normal controls. Quantitative RT-PCR was adopted to measurethe expression level of CYP27B1 gene. RESULTS: The expression levelof CYP27B1gene was significantly lower in the RRMS patients than theirnormal counterparts (P value = 0.04). Also, the RRMS females participating hada significant reduction in CYP27B1 gene expression compared to normalfemales (P-Value = 0.01). In addition, the correlation between CYP27B1expression level, and the risk of Expanded Disability Status Scaleof Kurtzke (EDSS) was not linear. Additionally, there was no significantcorrelation between expression status of CYP27B1gene and duration of thedisease. CONCLUSION: A significant decrease in the expression levelof CYP27A1 in female patients could indicate their greater vulnerability toMS than the male patients.

Journal

Human AntibodiesIOS Press

Published: Jan 1, 2017

There are no references for this article.